-DOCSTART- -X- O
Abstract -X- _ O
Recombinant -X- _ B-Intervention
Salmonella -X- _ I-Intervention
enterica -X- _ I-Intervention
serovar -X- _ I-Intervention
Typhi -X- _ I-Intervention
can -X- _ O
function -X- _ O
as -X- _ O
a -X- _ O
live -X- _ O
vector -X- _ O
to -X- _ O
deliver -X- _ O
foreign -X- _ O
antigens -X- _ O
to -X- _ O
the -X- _ O
mammalian -X- _ O
immune -X- _ O
system -X- _ O
and -X- _ O
induce -X- _ O
both -X- _ O
mucosal -X- _ O
and -X- _ O
systemic -X- _ O
immunity. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
generated -X- _ O
a -X- _ O
recombinant -X- _ B-Intervention
Salmonella -X- _ I-Intervention
Typhi -X- _ I-Intervention
strain -X- _ I-Intervention
pilS− -X- _ O
pilT−Gag+ -X- _ O
( -X- _ O
pVAX1-gp120 -X- _ O
) -X- _ O
harboring -X- _ O
the -X- _ O
human -X- _ O
immunodeficiency -X- _ O
virus -X- _ O
( -X- _ O
HIV -X- _ O
) -X- _ O
gag -X- _ O
gene -X- _ O
integrated -X- _ O
into -X- _ O
the -X- _ O
bacterial -X- _ O
chromosome -X- _ O
and -X- _ O
gp120 -X- _ O
gene -X- _ O
carried -X- _ O
by -X- _ O
a -X- _ O
plasmid. -X- _ O
Mice -X- _ B-Patient
inoculated -X- _ B-Outcome
with -X- _ I-Outcome
this -X- _ I-Outcome
recombinant -X- _ I-Outcome
bacterium -X- _ I-Outcome
through -X- _ I-Outcome
intranasal -X- _ I-Outcome
route -X- _ I-Outcome
produced -X- _ I-Outcome
high -X- _ I-Outcome
titers -X- _ I-Outcome
of -X- _ I-Outcome
IgG -X- _ I-Outcome
to -X- _ I-Outcome
gp120 -X- _ I-Outcome
in -X- _ I-Outcome
sera -X- _ I-Outcome
and -X- _ I-Outcome
IgA -X- _ I-Outcome
to -X- _ I-Outcome
gp120 -X- _ I-Outcome
in -X- _ I-Outcome
fecal -X- _ I-Outcome
washes. -X- _ I-Outcome
In -X- _ O
addition -X- _ O
, -X- _ O
Gag-specific -X- _ B-Outcome
and -X- _ I-Outcome
gp120-specific -X- _ I-Outcome
cytotoxic -X- _ I-Outcome
T -X- _ I-Outcome
lymphocyte -X- _ I-Outcome
( -X- _ I-Outcome
CTL -X- _ I-Outcome
) -X- _ I-Outcome
responses -X- _ I-Outcome
were -X- _ I-Outcome
observed -X- _ I-Outcome
in -X- _ I-Outcome
sorted -X- _ I-Outcome
spleen -X- _ I-Outcome
lymphocytes -X- _ I-Outcome
of -X- _ I-Outcome
immunized -X- _ I-Outcome
mice. -X- _ I-Outcome
These -X- _ O
results -X- _ O
demonstrated -X- _ O
that -X- _ O
this -X- _ O
recombinant -X- _ B-Outcome
Salmonella -X- _ I-Outcome
Typhi -X- _ I-Outcome
strain -X- _ I-Outcome
elicits -X- _ I-Outcome
multiple -X- _ I-Outcome
immune -X- _ I-Outcome
responses -X- _ I-Outcome
against -X- _ I-Outcome
both -X- _ I-Outcome
Gag -X- _ I-Outcome
and -X- _ I-Outcome
gp120 -X- _ I-Outcome
antigens -X- _ I-Outcome
of -X- _ I-Outcome
HIV -X- _ I-Outcome
, -X- _ O
and -X- _ O
thus -X- _ O
would -X- _ O
be -X- _ O
a -X- _ O
potential -X- _ O
vaccine -X- _ B-Intervention
candidate -X- _ O
to -X- _ O
the -X- _ O
prevention -X- _ O
of -X- _ O
HIV -X- _ O
/ -X- _ O
AIDS -X- _ O
. -X- _ O

